OFW Law Adds Team From Benjamin England & Associates
WASHINGTON, April 28, 2023 (Newswire.com)
–
Two of the nation’s premier firms focusing on food, drugs, agriculture, and medical device clients are joini…
h2o Therapeutics Announces Collaboration With AmerisourceBergen to Support the Commercialization of Apple Watch-Based App Parky for Parkinson’s Disease
ANKARA, Turkey & CONSHOHOCKEN, Penn., April 28, 2023 (Newswire.com)
–
Digital health start-up h2o Therapeutics today announced a collaboration with global healthcare company AmerisourceBergen to support the commercialization of Parky, a prescription mobile app cleared by the U.S. Food and Drug Administration (FDA) for monitoring certain symptoms in adults with Parkinson’s Disease.
The Parky app, which is compatible with the Movement Disorder API developed by Apple Inc., monitors symptoms such as tremors and dyskinesia in real time via the use of Apple Inc.’s Apple Watch. It is a direct-to-patient tool for sharing meaningful and reliable data between patients and medical professionals regarding the course of the disease. As part of a pilot arrangement, AmerisourceBergen will facilitate patient engagement and health system integration services as part of its DTx Connect solution.
“Following the recent FDA clearance, we continue to focus on strategies and solutions that will enable us to expand patient access to Parky,” said Yagmur Selin Gulmus, the founder of h2o Therapeutics. “Through this arrangement with AmerisourceBergen, our goal is to reduce barriers along the patient journey, improve access and expand our commercial reach. In support of the Parkinson’s Disease community, we are proud to launch our patient-oriented technology during Parkinson’s Awareness Month.”
“Digital therapeutics offer tremendous potential, but developers face unique challenges that can affect market access and product potential,” said Alex Kilgore, PharmD, Product Manager, Global Products and Solutions at AmerisourceBergen. “We look forward to supporting h2o Therapeutics and will leverage our digital health capabilities to help patients start on the Parky app following a prescription.”
Parkinson’s Disease, the fastest-growing neurological disorder, affects more than 10 million people worldwide, including about one million people in the United States, according to the Parkinson’s Foundation. The Parky App aims to help healthcare providers develop a profile of the patient in daily life, bridging the gap between real-life and in-clinic settings.
AmerisourceBergen offers a wide range of services to support DTx developers and biopharmaceutical companies across the commercialization journey, including market access consulting, distribution and patient support services. The company in 2022 announced its plans to develop and launch DTx Connect, a cloud-based, fully integrated ordering, dispensing, and fulfillment platform that aims to facilitate patient access to physician-ordered digital therapeutics and digital diagnostics.
“During Parkinson’s Awareness Month, AmerisourceBergen could not be prouder to stand together with Parkinson’s Disease patients, their families and healthcare providers, and innovative digital health technology developers like h2o Therapeutics to support the best patient care,” said Jason Dinger, Senior Vice President of Global Products and Solutions at AmerisourceBergen.
About h2o Therapeutics
h2o Therapeutics is developing digital therapeutics with a focus on wearable technologies, Augmented Reality (AR), and Artificial Intelligence (AI). h2o intends to make real-time human data become a handy tool for disease management in certain therapeutic areas. Our core understanding of digital therapeutics lies in the power of AI, the robustness of their clinical health research, and high levels of user engagement. Parky, a Parkinson’s Disease prescription mobile app, received 510(k) clearance from the FDA in 2022.
About AmerisourceBergen
AmerisourceBergen is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 44,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500 and #21 on the Global Fortune 500 with more than $200 billion in annual revenue. Learn more at www.amerisourcebergen.com.
Contact Information:
Yagmur Selin Gulmus
Founder
Hande Erciyes
Operations Manager
Original Source:
h2o Therapeutics Announces Collaboration With AmerisourceBergen to Support the Commercialization of Apple Watch-Based App Parky for Parkinson’s Disease
h2o Therapeutics Announces Collaboration With AmerisourceBergen to Support the Commercialization of Apple Watch-Based App Parky for Parkinson’s Disease
ANKARA, Turkey & CONSHOHOCKEN, Penn., April 28, 2023 (Newswire.com)
–
Digital health start-up h2o Therapeutics today announced a collaboration with global healthcare company AmerisourceBergen to support the commercialization of Parky, a prescription mobile app cleared by the U.S. Food and Drug Administration (FDA) for monitoring certain symptoms in adults with Parkinson’s Disease.
The Parky app, which is compatible with the Movement Disorder API developed by Apple Inc., monitors symptoms such as tremors and dyskinesia in real time via the use of Apple Inc.’s Apple Watch. It is a direct-to-patient tool for sharing meaningful and reliable data between patients and medical professionals regarding the course of the disease. As part of a pilot arrangement, AmerisourceBergen will facilitate patient engagement and health system integration services as part of its DTx Connect solution.
“Following the recent FDA clearance, we continue to focus on strategies and solutions that will enable us to expand patient access to Parky,” said Yagmur Selin Gulmus, the founder of h2o Therapeutics. “Through this arrangement with AmerisourceBergen, our goal is to reduce barriers along the patient journey, improve access and expand our commercial reach. In support of the Parkinson’s Disease community, we are proud to launch our patient-oriented technology during Parkinson’s Awareness Month.”
“Digital therapeutics offer tremendous potential, but developers face unique challenges that can affect market access and product potential,” said Alex Kilgore, PharmD, Product Manager, Global Products and Solutions at AmerisourceBergen. “We look forward to supporting h2o Therapeutics and will leverage our digital health capabilities to help patients start on the Parky app following a prescription.”
Parkinson’s Disease, the fastest-growing neurological disorder, affects more than 10 million people worldwide, including about one million people in the United States, according to the Parkinson’s Foundation. The Parky App aims to help healthcare providers develop a profile of the patient in daily life, bridging the gap between real-life and in-clinic settings.
AmerisourceBergen offers a wide range of services to support DTx developers and biopharmaceutical companies across the commercialization journey, including market access consulting, distribution and patient support services. The company in 2022 announced its plans to develop and launch DTx Connect, a cloud-based, fully integrated ordering, dispensing, and fulfillment platform that aims to facilitate patient access to physician-ordered digital therapeutics and digital diagnostics.
“During Parkinson’s Awareness Month, AmerisourceBergen could not be prouder to stand together with Parkinson’s Disease patients, their families and healthcare providers, and innovative digital health technology developers like h2o Therapeutics to support the best patient care,” said Jason Dinger, Senior Vice President of Global Products and Solutions at AmerisourceBergen.
About h2o Therapeutics
h2o Therapeutics is developing digital therapeutics with a focus on wearable technologies, Augmented Reality (AR), and Artificial Intelligence (AI). h2o intends to make real-time human data become a handy tool for disease management in certain therapeutic areas. Our core understanding of digital therapeutics lies in the power of AI, the robustness of their clinical health research, and high levels of user engagement. Parky, a Parkinson’s Disease prescription mobile app, received 510(k) clearance from the FDA in 2022.
About AmerisourceBergen
AmerisourceBergen is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 44,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500 and #21 on the Global Fortune 500 with more than $200 billion in annual revenue. Learn more at www.amerisourcebergen.com.
Contact Information:
Yagmur Selin Gulmus
Founder
Hande Erciyes
Operations Manager
Original Source:
h2o Therapeutics Announces Collaboration With AmerisourceBergen to Support the Commercialization of Apple Watch-Based App Parky for Parkinson’s Disease
James Shapiro’s 1599: A Year in the Life of William Shakespeare Wins the Baillie Gifford Prize for Non-Fiction Winner of Winners Award
The one-off award marks the 25th anniversary of the prize by recognising the outstanding work of all previous 24 prizewinners. Shapiro’s 1599: A Year in the Life of William Shakespeare won the prize in 2006 and explores the year that Shakespeare produced some of his greatest works
Baillie Gifford Prize Winner of Winners James Shapiro
Baillie Gifford Prize Winner of Winners James Shapiro with 1599: A Year in the Life of William Shakespeare at a photocall at Waterstones in Edinburgh
EDINBURGH, Scotland, April 27, 2023 (Newswire.com)
–
1599: A Year in the Life of William Shakespeare by James Shapiro is tonight, Thursday, April 27, named winner of the Baillie Gifford Prize for Non-Fiction ‘Winner of Winners’ Award. The winner was announced by Chair of Judges, Jason Cowley, at a ceremony hosted at the National Museum of Scotland, Edinburgh.
The Baillie Gifford Prize for Non-Fiction Winner of Winners Award marks the 25th anniversary of the UK’s premier non-fiction book prize by crowning the best work of non-fiction from the last 25 years of the prize. As the winner, Shapiro will receive £25,000.
The winner was chosen by a judging panel comprising of: New Statesman editor-in-chief, Jason Cowley (chair); academic, critic and broadcaster, Shahidha Bari; journalist, author and academic, Sarah Churchwell; and biographer and critic Frances Wilson. Their selection was made from a shortlist of six books, taken from the previous 24 prizewinning books.
In the course of 1599, Shakespeare completed Henry V, wrote Julius Caesar and As You Like It in quick succession, and produced the first draft of his greatest play, Hamlet. In his winning book 1599: A Year in the Life of William Shakespeare, Shapiro shows how The Bard progressed from his tale of two star-crossed lovers to Hamlet. Shapiro finds one question the most pressing: how did Shakespeare become Shakespeare – one of the greatest writers who ever lived?
James Shapiro is Professor of English at Columbia University, where he teaches Shakespeare. His earlier books have received international acclaim, including 1606: The Year of Lear, which won the James Tait Black Prize; 1599: A Year in the Life of William Shakespeare, which won the Samuel Johnson Prize; and Shakespeare in a Divided America, selected as one of the 10 best books of the year by the New York Times. Shapiro is also the author of Contested Will: Who Wrote Shakespeare?, Oberammergau: The Troubling Story of the World’s Most Famous Passion Play, Shakespeare and the Jews, and Rival Playwrights: Marlowe, Shakespeare, Jonson, and edited the Library of America anthology, Shakespeare in America. His reviews have appeared in The New York Times Book Review, Times Literary Supplement, the London Review of Books, and other publications. He has served on the board of directors of The Royal Shakespeare Company, and advises productions for the Public Theatre in New York and other companies. Shapiro was a collaborator on The King and the Playwright, a series he hosted for the BBC and also hosted the BBC The Mysterious Mr. Webster. In 2011, he was inducted into the American Academy of Arts and Sciences. He is currently serving as a Booker Prize judge.
Jason Cowley, Chair of judges, says:
“1599 is a remarkable and compelling book. A history of four masterpieces and of so much more, it produces a life of Shakespeare, about whom so little is known, through an ingenious fusion of history, politics, and literary criticism. The result is a poised and original re-imagination of biography. Shapiro returns Shakespeare to the stage of his own world, and in so doing, he transforms our understanding – not only of the great works but also of the social atmosphere of his times. Erudite, accessible and formally bold, it will appeal to anyone interested in history, politics, literature and good writing.”
Peter Singlehurst, Partner at Baillie Gifford, says:
“The strapline for the Baillie Gifford Prize is ‘all the best stories are true’. But it is not necessarily their factfulness that makes these books so special, it is the stories about people, ordinary and extraordinary. Choosing one book seems an impossible task and we thank the judges for taking on the unenviable responsibility. Many congratulation to James Shapiro.”
Sir Leonard Blavatnik, Head of the Blavatnik Family Foundation, says:
“For twenty-five years, the Baillie Gifford Prize for Non-Fiction has recognized immensely talented authors. We congratulate James Shapiro on this exceptional achievement. We are proud to be the long-time sponsor of the podcasts showcasing the short-listed books and their authors, as well as the annual celebratory gala in London when the winners are announced.”
thebailliegiffordprize.co.uk | @BGPrize | #BGPrize25
Images of the winning author and book are available to download here.
This folder is being updated with images from the ceremony.
Contact Information:
Nathaniel Ashley
Account Executive
+44 (0)20 3103 9598
Julie Holman
Account Director
+44 (0)7841 672 393
Related Files
The Baillie Gifford Prize for Non-Fiction Winner of Winners Award – Winner Announced – FOR IMMEDIATE RELEASE.pdf
Original Source:
James Shapiro’s 1599: A Year in the Life of William Shakespeare Wins the Baillie Gifford Prize for Non-Fiction Winner of Winners Award
The post James Shapiro’s 1599: A Year in the Life of William Shakespeare Wins the Baillie Gifford Prize for Non-Fiction Winner of Winners Award first appeared on RSVTV news.
Shepherd’s Village Launches the Single Solution
TAMPA, Fla., April 27, 2023 (Newswire.com)
–
In April 2023, Shepherd’s Village launched The Single Solution, a $14.99 monthly gift-giving subscription plan that provides ongoing support to single mothers in need. For the cost of an average monthly streaming service, The Single Solution is a simple way to impact the community and open the door for single mothers to gain vital resources for their families.
As the only faith-based program for single mothers in Pinellas County, FL, for the last 32 years, Shepherd’s Village is uniquely positioned to stand in the gap for single moms and their children.
The Single Solution will provide one single mother with the following:
- Free unlimited access to online resources specific to her needs
- Free and convenient classes, workshops, and coaching
- Additional online and in-person community support
- 24-hour live prayer partner support
- Cost-effective conferences and conversations
- Provision for other practical needs as they arise
Signup for The Single Solution is easy and can be canceled anytime. There is no risk and no long-term commitment involved.
For more information and to start The Single Solution monthly gift-giving subscription, please visit our website at https://www.shepherdsvillage.com/subscribe. We look forward to helping more Tampa Bay single moms face their future with confidence.
####
Based in Tampa Bay, FL, Shepherd’s Village stands in the gap for single mothers and their children. While we are the only faith-based single-mother housing program in Pinellas County, Florida, we have expanded our free online offerings so more women across the country can experience healing, safety, and restoration. With the help of our partners, we are able to reach two generations at one time and make an impact that will long outlive us.
There is hope beyond the brokenness and confusion caused by divorce, separation, death, or never having been married. If you know a single mother in need, please direct them to our website for life-changing resources: https://shepherdsvillage.com/.
Contact Information:
Briana Yates
Project Manager- Marketing
7277442447
Original Source:
Shepherd’s Village Launches the Single Solution
The post Shepherd’s Village Launches the Single Solution first appeared on RSVTV news.
Clearview Outpatient Mental Health Treatment Clinic Opens in Long Beach, California
The Odyssey Outpatient Network expands its continuum of care, supporting a full spectrum of mental health disorders in Long Beach California
Clearv…
Survey: More than half of Americans struggle with confidence when speaking a second language, unless alcohol is involved
60% of US adults reported feeling more confident speaking another language after having a few alcoholic drinks, a recent poll from Lingoda finds
Li…
The post Survey: More than half of Americans struggle with confidence when speaking a second language, unless alcohol is involved first appeared on RSVTV news.
BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim – a New Model for Building an External Innovation Ecosystem on an Industry Campus
XSeed Labs – Powered by BioMed X
RIDGEFIELD, Conn., April 27, 2023 (Newswire.com)
–
BioMed X announced today the expansion of its collaboration with Bo…
WoundZoom Partners With MolecuLight to Deliver a Cloud-Based Wound Management Solution Integrated With Its Point-of-Care Bacterial Imaging
Wound Care Clinicians Can Now Manage All Wound Care Documentation, MolecuLight Images and Measurements via a Robust, Scalable Cloud Platform
…
Kwento Comics and Lumpia With A Vengeance Collab at HiFi Kitchen for Free Comic Book Day
Filipino American comic book creators and special guests come together to give away a free digital comic book copy and promote tasty Filipino food and beverages at HiFi Kitchen on May 6, 2023.
…
The post Kwento Comics and Lumpia With A Vengeance Collab at HiFi Kitchen for Free Comic Book Day first appeared on RSVTV news.